ArticleThe Prostate2026

Impact of Intraprostatic Simultaneous Integrated Boost on Long-Term Outcomes in Unfavorable Intermediate-Risk Prostate Cancer Treated With Dose-Escalated Radiotherapy and Short-Term Androgen Deprivation Therapy.

Cem Onal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.